Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Kenneth C. Shadlen"'
Autor:
Deborah Gleeson, Joel Lexchin, Ronald Labonté, Belinda Townsend, Marc-André Gagnon, Jillian Kohler, Lisa Forman, Kenneth C. Shadlen
Publikováno v:
Globalization and Health, Vol 15, Iss S1, Pp 1-17 (2019)
Abstract Background Trade and investment agreements negotiated after the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) have included increasingly elevated protection of intellectual property r
Externí odkaz:
https://doaj.org/article/2c37946aa5c14aacacd5211ca6097a07
Autor:
Kenneth C. Shadlen
When countries become more democratic, new opportunities arise for individuals and groups to participate in politics and influence the making of policy. But democratization does not ensure better representation for everyone, and indeed some sectors o
Autor:
Kenneth C, Shadlen
Publikováno v:
The Lancet. 400:632-634
Autor:
Bhaven N Sampat, Kenneth C Shadlen
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194714 (2018)
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" pharmaceutical patents, i.e. patents on new forms of e
Externí odkaz:
https://doaj.org/article/17b32fee798a4952b5f2df7211850780
Autor:
Kenneth C. Shadlen, Bhaven N. Sampat
Publikováno v:
Health Affairs. 40:400-409
The coronavirus disease 2019 (COVID-19) pandemic response brought forth major changes in innovation policy. This article takes stock of the key features of the COVID-19 innovation system-the network of public and private actors influencing the develo
Publikováno v:
Journal of International Business Policy
In this introduction to the special issue, we take stock of the impact of the TRIPS agreement on international business in the hyper-globalised world of the late twentieth and early twenty-first century. We begin by providing a brief background on TR
As the world struggles to meet the challenges of vaccination against COVID-19, more attention needs to be paid to issues faced by countries at different income levels. Middle-income countries (MICs) typically lack the resources and regulatory capacit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b63da4100d64ad8c580a3ed7c365d38
http://eprints.lse.ac.uk/110736/
http://eprints.lse.ac.uk/110736/
Autor:
Olivier J. Wouters, Heidi J. Larson, Mark Jit, Andrew J. Pollard, Kenneth C. Shadlen, Maximilian Salcher-Konrad, Yot Teerawattananon
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use,
Autor:
Bhaven N, Sampat, Kenneth C, Shadlen
Publikováno v:
Health affairs (Project Hope). 40(3)
The coronavirus disease 2019 (COVID-19) pandemic response brought forth major changes in innovation policy. This article takes stock of the key features of the COVID-19 innovation system-the network of public and private actors influencing the develo
Autor:
Kenneth C. Shadlen
Since the late 1980s, developing countries have come under considerable pressure to revise their policies and practices with regard to intellectual property. One area where pressures have been exceptionally strong, and also controversial, is in pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeb48e0f834f75ca388bb164c454fdc0
https://doi.org/10.1093/acrefore/9780190228637.013.1519
https://doi.org/10.1093/acrefore/9780190228637.013.1519